All the included studies detected PD-L1 expression by immunohistochemistry (IHC), eight studies only detected the PD-L1 expression in tumour cells (TCs), four trials only in tumour-inflating immune cells (TIICs), and two studies measured PD-L1 in both locations. This evidence concerns the gene CD274 and neoplasm.